日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease Inhibitors

基于结构的超广谱3C样蛋白酶抑制剂的开发

Su, Haixia; Nie, Tianqing; Chen, Guofeng; Xiong, Muya; Zhang, Yumin; Wu, Guoqing; You, Mengyuan; Xie, Hang; He, Jian; Xiong, Yanchao; Hu, Hangchen; Zhao, Wenfeng; Li, Minjun; Xiao, Gengfu; Zhang, Leike; Xu, Yechun

De novo design of protein condensation inhibitors by targeting an allosteric site of cGAS.

通过靶向 cGAS 的变构位点,从头设计蛋白质缩合抑制剂

Zhao Wenfeng, Chen Guofeng, He Jian, Shen Xiaofang, Xiong Muya, Xiong Liwei, Qi Zhihao, Xie Hang, Li Wanchen, Li Jiameng, Dou Huixia, Hu Hangchen, Su Haixia, Shao Qiang, Li Minjun, Sun Hongbin, Xu Yechun

Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.

基于结构的高效选择性RIPK3抑制剂设计,可消除体外靶向毒性

Su Haixia, Chen Guofeng, Xie Hang, Li Wanchen, Xiong Muya, He Jian, Hu Hangchen, Zhao Wenfeng, Shao Qiang, Li Minjun, Zhao Qiang, Xu Yechun

Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease

猴痘病毒I7L蛋白酶的动态帽介导底物进入和强效抑制剂设计

Su, Haixia; Wu, Guoqing; Xiong, Muya; Wang, Yuhang; Cao, Junyuan; You, Mengyuan; Xiang, Yingchun; Nie, Tianqing; Li, Minjun; Xiao, Gengfu; Zhang, Leike; Shao, Qiang; Xu, Yechun

Joint ensemble learning-based risk prediction of Alzheimer's disease among mild cognitive impairment patients

基于联合集成学习的轻度认知障碍患者阿尔茨海默病风险预测

Guan, Tianyuan; Shang, Lei; Yang, Peng; Tan, Zhijun; Liu, Yue; Dong, Chunling; Li, Xueying; Hu, Zuxuan; Su, Haixia; Zhang, Yuhai

HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases

乙肝病毒急性期和慢性期患者中HBsAg和抗-HBs共存

Pu, Zhongshu; Ji, Zhaohua; Su, Haixia; Fu, Ting; Shao, Zhongjun; Yan, Yongping

Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment

发现新型非肽类和非共价小分子3CL(pro)抑制剂作为COVID-19治疗的潜在候选药物

Jiang, Zhidong; Feng, Bo; Zhang, Yumin; Nie, Tianqing; Liu, Hong; Li, Jia; Su, Haixia; Zhang, Leike; Zang, Yi; Zhou, Yu

Multi-omics for COVID-19: driving development of therapeutics and vaccines

新冠病毒多组学:推动治疗药物和疫苗的研发

Guo, Mengyu; Xiong, Muya; Peng, Jinying; Guan, Tong; Su, Haixia; Huang, Yanyi; Yang, Cai-Guang; Li, Yang; Boraschi, Diana; Pillaiyar, Thanigaimalai; Wang, Guanbo; Yi, Chengqi; Xu, Yechun; Chen, Chunying

Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19

华石百度汤中的生物活性成分对新冠病毒具有抗病毒和抗炎作用。

Xu, Haiyu; Li, Shufen; Liu, Jiayuan; Cheng, Jinlong; Kang, Liping; Li, Weijie; Zhong, Yute; Wei, Chaofa; Fu, Lifeng; Qi, Jianxun; Zhang, Yulan; You, Miaomiao; Zhou, Zhenxing; Zhang, Chongtao; Su, Haixia; Yao, Sheng; Zhou, Zhaoyin; Shi, Yulong; Deng, Ran; Lv, Qi; Li, Fengdi; Qi, Feifei; Chen, Jie; Zhang, Siqin; Ma, Xiaojing; Xu, Zhijian; Li, Shao; Xu, Yechun; Peng, Ke; Shi, Yi; Jiang, Hualiang; Gao, George F; Huang, Luqi

Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches

利用多尺度计算方法揭示SARS-CoV-2木瓜蛋白酶样蛋白酶的催化机制及其对C270突变的变构调节作用

Shao, Qiang; Xiong, Muya; Li, Jiameng; Hu, Hangchen; Su, Haixia; Xu, Yechun